DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Boni C, Penna A, Ogg GS. , et al.
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.
Hepatology 2001;
33 (04) 963-971
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.